Page 3 - Research Development Corp News Today

Phase 3 trial reached primary endpoint and demonstrated a reduction in SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours

When: Penn Township supervisors meeting, Jan. 10.

The House Transportation Committee is considering legislation to permit personal delivery devices to one day operate on all sidewalks and crosswalks and along the side of roadways in the state.

Satellite Healthcare Participates in Clinical Trial With Home Hemodialysis Machine Effort aims to empower patients to choose home hemodialysis with confidence AUSTIN, Texas--(BUSINESS WIRE)--Satellite Healthcare today announced it will participate in an ongoing clinical trial sponsored by DEKA Research & Development Corp. (DEKA). The study is investigating the clinical use of the HemoCare® Hemodialysis System, a new home hemodialysis machine that has been designed by DE...

Message : Required fields SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 5, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2021. Total revenue in the first quarter of 2021 grew 6% year over year to $379.1 million, compared to $356.3 million in the first quarter of 2020. "2021 is already a historic year for United Therapeutics, with the recent FDA approval and launch of Tyvaso for treatment of...

United Therapeutics Corporation Reports First Quarter 2021 Financial Results Tyvaso® (treprostinil) Inhalation Solution approved for pulmonary hypertension associated with interstitial lung disease (PH-ILD) Tyvaso DPI™ New Drug Application (NDA) submitted to U.S. Food and Drug Administration TETON study of Tyvaso in idiopathic pulmonary fibrosis (IPF) expected to enroll its first patients in the second quarter of 2021 News provided by Share this article Share this article SILVER SPRING, Md. ...

Does South Bethlehem need more 150-foot-tall buildings? Plan aims to shrink max heights. Updated 8:49 AM; Today 7:59 AM East Third Street on Southside Bethlehem is seen Jan. 11, 2019, from Zest bar+grill atop the Gateway at Greenway Park.Saed Hindash file photo | For lehighvalleylive.com Facebook Share Bethlehem planning officials and consultants are continuing to look at what kind of development the community would like to see over the next 15 years, including maximum building heights and de...

A study aiming to balance future development with the charm of Bethlehem’s South Side Historic Conservation District recommends increasing building heights from 60 feet to 90 feet in one portion of the central business district, while dropping them from 150 feet to 60 feet elsewhere in the district.